:quality(50))
:quality(50))
Infermedica raises $30 M in Series B funding
We’re proud to announce another landmark occasion that enables Infermedica’s growth on a mission for better healthcare.
:quality(50))
Infermedica 2021: Year in Review
A roundup of what we’ve accomplished in 2021, and what’s to come next year from Infermedica’s CEO, Piotr Orzechowski.
:quality(50))
Infermedica 2020: Year in review
Infermedica navigated through 2020 and despite all obstacles, we kept supporting global healthcare to bring better health services. See what we achieved.
:quality(50))
Infermedica closes Series A funding with $10.25M
We are entering the next stage of growth. See how the new funds will accelerate the development of our AI-based solutions for healthcare.
:quality(50))
COVID-19 Risk Assessment tool is here
As the pandemic emerged, our team worked non-stop and released a free COVID-19 risk evaluation tool.
:quality(50))
COVID-19 and Infermedica
COVID-19 is more than just a hot topic. Helping patients quickly assess their risk of coronavirus is how we are fighting this global crisis.
:quality(50))
Infermedica 2019: Year in Review
2019 was a breakthrough. We've managed to grow our team, gain new clients, improve the product, and raise additional funding.
:quality(50))
Infermedica raises $3.65M in a new round of funding
Our initial idea has turned into a bold mission to guide every patient to the best possible care, gaining new allies along the way.
